efficacy and efficiency," said John Milligan, Gilead's President and chief executive officer. "We believe Sangamo's zinc finger nucleases provide the optimal gene-editing platform, and we look ...
Since then, BOSS has sponsored 21 seminars featuring industry leaders. BOSS has hosted John Milligan, President and Chief Operating Officer of Gilead Sciences and Thomas Harding, Senior Vice President ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback